Search alternatives:
point decrease » point increase (Expand Search)
fold decrease » fold increase (Expand Search), fold increased (Expand Search)
n decrease » nn decrease (Expand Search), _ decrease (Expand Search), _ decreased (Expand Search)
a decrease » _ decrease (Expand Search), _ decreased (Expand Search), _ decreases (Expand Search)
point decrease » point increase (Expand Search)
fold decrease » fold increase (Expand Search), fold increased (Expand Search)
n decrease » nn decrease (Expand Search), _ decrease (Expand Search), _ decreased (Expand Search)
a decrease » _ decrease (Expand Search), _ decreased (Expand Search), _ decreases (Expand Search)
-
981
POS treatment decreases ROS level and upregulates mitochondrial biogenesis in ARPE-19 cells through PGC-1α.
Published 2015“…<b>(B)</b> POS treatment downregulated the Intracellular ROS levels evaluated by H<sub>2</sub>DCFDA. Mean ± SEM, n = 6 per group, two-tailed Student’s <i>t</i>-test, **<i>P</i> < 0.01, ***<i>P</i> < 0.001; ns, not significant. …”
-
982
-
983
-
984
-
985
-
986
Treatment with SMIFH2 decreases the actin level in oocytes and impairs spindle formation.
Published 2015“…<p><b>A</b>. Treatment with SMIFH2 decreases the cortical actin level in maturing mouse oocytes. …”
-
987
-
988
-
989
-
990
Anesthetics differentially decrease cilia-driven particle transport speed (PTS).
Published 2016“…<b>(B)</b> HEPES (solvent of isoflurane) alone also had no effect on PTS. N = 2 tracheas from 2 animals. <b>(C)</b> Avertin® (0.4 mM) decreased PTS significantly. …”
-
991
-
992
VGB treatment decreased the number of GFAP positive cells in hippocampus of <i>Tsc1</i><sup>GFAP</sup>CKO mice.
Published 2013“…#p<0.05, ## p<0.01, ### p<0.001 versus vehicle-treated control mice by two-way ANOVA (n = 4–5 mice/group). VGB treatment decreased GFAP-positive cells in <i>Tsc1</i><sup>GFAP</sup>CKO mice (KO+VGB). …”
-
993
-
994
-
995
-
996
-
997
-
998
-
999
-
1000